Anzeige
Mehr »
Login
Donnerstag, 06.06.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Breaking the Wall: Uranmarkt geht wieder steil! Warum Sie hier dabei sein sollten!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Übersicht Suchergebnisse zum Thema AMPIO PHARMACEUTICALS INC.

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
15.04.Ampio Pharmaceuticals, Inc. - 15-12G, Securities registration termination2
04.04.Ampio Pharmaceuticals, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities1
03.04.Ampio Pharmaceuticals, Inc.: Ampio Pharmaceuticals Received Audit Opinion with Going Concern Explanation45ENGLEWOOD, Colo., April 3, 2024 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company" or "Ampio") today announced that, as previously disclosed in its Annual Report on Form...
► Artikel lesen
27.03.Ampio Pharmaceuticals, Inc. - 10-K, Annual Report1
25.03.Ampio Pharmaceuticals, Inc. - 8-K, Current Report1
25.03.Ampio Pharmaceuticals, Inc.: Ampio Announces Voluntary Delisting and SEC Deregistration153ENGLEWOOD, Colo., March 25, 2024 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company" or "Ampio") today announced that its Board of Directors determined to voluntarily...
► Artikel lesen
28.02.Ampio Pharmaceuticals, Inc. - 8-K, Current Report1
15.02.Ampio Pharmaceuticals, Inc. - 8-K, Current Report2
14.02.Ampio Pharmaceuticals, Inc.: Ampio Provides Update on Results from Pre-IND Enabling Studies177ENGLEWOOD, Colo., Feb. 14, 2024 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the "Company" or "Ampio"), a pre-revenue stage biopharmaceutical company focused on development...
► Artikel lesen
25.01.Ampio Pharmaceuticals, Inc. - 8-K, Current Report1
11.01.Ampio Pharmaceuticals, Inc. - 8-K, Current Report1
21.12.23Ampio Pharmaceuticals, Inc. - S-1, General form for registration of securities3